The Middle East and Africa lab diagnostics market encompasses a dynamic healthcare landscape characterized by technological advancements and evolving diagnostic methodologies. With a focus on disease detection, monitoring, and management, the region experiences a growing demand for innovative diagnostic solutions. Factors such as increasing healthcare awareness, and infrastructure development contribute to market expansion. The MEA lab diagnostics sector includes clinical chemistry, immunoassays, molecular diagnostics, and hematology among other key segments. The Middle East and Africa lab diagnostics market reflects a quest for accurate and timely diagnostics, essential for improving overall healthcare outcomes in the region.
Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lab-diagnostics-market
Data Bridge Market Research analyses that the Middle East and Africa Lab Diagnostics Market which was USD 5,282.63 million in 2022, is expected to reach USD 8,168.87 million by 2030, at a CAGR of 5.60% during the forecast period 2023 to 2030. The aging demographic in the region contributes to a higher incidence of age-related diseases, necessitating increased diagnostic services, and subsequently, driving market growth.
Key Findings of the Study
Increasing disease burden is expected to drive the market's growth rate
The rising incidence of chronic diseases such as diabetes, cardiovascular ailments, and infectious conditions propels the demand for sophisticated diagnostic tools and techniques. As these health challenges become more prevalent in the Middle East and Africa, there is a growing necessity for advanced diagnostics to enable accurate and timely disease identification. This surge in demand underscores the pivotal role played by cutting-edge diagnostic technologies in addressing the region's increasing disease burden.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Solution (Product Type and Test Type), Test Type (Clinical Chemistry and Immunoassays, Infectious Disease Testing, Microbiology, Mycology and Parasitology, Haematology, POCT, Human Chorionic Gonadotropin (HCG), and Others), Product Type (Reagents and Consumables, Analysers and Instruments, and Accessories), Sample Type (Blood, Urine, Sputum, Tissue, and Others), Therapeutic Area (Metabolic Disorders, Infections, Oncology, Genetic Disorders, Urology, Gynaecology, and Others), End User (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, and Others), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributor)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Abbott. (U.S.), B.D. (U.S.), COSMED srl (Italy), Thermo Fisher Scientific Inc. (U.S.), Carestream Health (U.S.), VYAIRE (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), Danaher (U.S.), Trinity Biotech (Ireland), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific Inc. (U.S.), BIOMÉRIEUX (France)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Middle East and Africa lab diagnostics market is segmented on the basis of solution, test type, product type, sample type, therapeutic area, end user and distribution channel.
- On the basis of solution, the Middle East and Africa lab diagnostics market is segmented into product type and test type
- On the basis of test type, the Middle East and Africa lab diagnostics market is segmented into clinical chemistry and immunoassays, infectious disease testing, microbiology, mycology and parasitology, haematology, POCT, human chorionic gonadotropin (HCG), and others
- On the basis of product type, the Middle East and Africa lab diagnostics market is segmented into reagents and consumables, analysers and instruments, and accessories
- On the basis of sample type, the Middle East and Africa lab diagnostics market is segmented into blood, urine, sputum, tissue, and others
- On the basis of therapeutic area, the Middle East and Africa lab diagnostics market is segmented into metabolic disorders, infections, oncology, genetic disorders, urology, gynaecology, and others
- On the basis of end user, the Middle East and Africa lab diagnostics market is segmented into hospital-based labs, stand-alone labs, diagnostic chains, and others
- On the basis of distribution channel, the Middle East and Africa lab diagnostics market is segmented into direct tender, retail sales, and third party distributor
Major Players
Data Bridge Market Research recognizes the following companies as the major Middle East and Africa lab diagnostics market players in Middle East and Africa lab diagnostics market are Quidel Corporation (U.S.), Danaher (U.S.), Trinity Biotech (Ireland), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific Inc. (U.S.), BIOMÉRIEUX (France)
Market Developments
- In September 2021, F. Hoffmann-La Roche Ltd unveiled three molecular PCR diagnostic test panels, designed to concurrently identify and distinguish prevalent respiratory pathogens. This strategic product launch was expected to significantly bolster the company's revenue growth by addressing the increasing demand for advanced diagnostic solutions in the field of respiratory infections and supporting timely and accurate detection
- In August 2021, Danaher successfully acquired Aldevron, integrating it as a standalone operating entity and brand under Danaher's Life Sciences segment. This strategic acquisition has significantly expanded the company's product portfolio, reinforcing its position in the life sciences industry and enhancing its capabilities in providing innovative solutions to the market
- In March 2021, F. Hoffmann-La Roche Ltd expanded its cobas pro integrated solutions, introducing eight new configurations in CE mark-accepting countries. This enhancement doubled the analyzer's testing capacity to 4,400 tests per hour, showcasing Roche's commitment to technological innovation. The launch aimed to significantly boost the company's geographical presence and reinforce its position in the global diagnostic solutions market
- In March 2020, Thermo Fisher unveiled its acquisition of QIAGEN N.V., aiming to broaden its specialty diagnostics portfolio. The strategic move incorporates QIAGEN's molecular diagnostics expertise, particularly in infectious disease testing. The integration also leverages QIAGEN's instruments for workflow automation and bioinformatics systems, furnishing customers with valuable, actionable insights
Regional Analysis
Geographically, the countries covered in the Middle East and Africa lab diagnostics market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
As per Data Bridge Market Research analysis:
South Africa is estimated to be the fastest growing region in the Middle East and Africa lab diagnostics market during the forecast period 2023-2030
South Africa is expected to dominate the Middle East and Africa lab diagnostics market, owing to its expansive consumer base. The surge is attributed to technological advancements, a rise in chronic diseases, heightened awareness of early diagnosis, and a growing demand for lab diagnostics. These factors collectively contribute to propelling market growth, positioning South Africa as a key leader in driving advancements and adoption of diagnostic solutions in the region.
For more detailed information about the Middle East and Africa lab diagnostics market report, click here – https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lab-diagnostics-market
